| Part Number : NDC00024-5843-05 | Manufacturer : Sanofi Pasteur Inc | ||
| NSN : 6505-01-654-2233 (6505016542233) | |||
| Item Name : Sargramostim For Injection | CAGE Code : 7V915 | ||
| NIIN : 01-654-2233 (016542233) | |||
| INC Code : 47171 | |||
| NCB Code : 01 | Country : USA | ||
| Alternate P/N: NDC00024584305 | |||
Thank you for taking an interest in part number NDC00024-5843-05, that of which is listed with the description Sargramostim For Injection; Manufactured by Sanofi Pasteur Inc and listed alongside the NSN 6505016542233, part number NDC00024-5843-05 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
| Part Number : NDC00024-5843-05 | Manufacturer : Sanofi Pasteur Inc | ||
| NSN Number : 6505-01-654-2233 (6505016542233) | |||
| Item Name : Sargramostim For Injection | CAGE Code : 7V915 | ||
| NIIN : 016542233 | |||
Thank you for taking an interest in part number NDC00024-5843-05, that of which is listed with the description Sargramostim For Injection; Manufactured by Sanofi Pasteur Inc and listed alongside the NSN 6505016542233, part number NDC00024-5843-05 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-654-2233 Item PartTypeName: SARGRAMOSTIM FOR INJECTION | 6505 | 016542233 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | 0 | ||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| NDC71837-5843-05 | 5 | 2 | 3 |
| MRC | Criteria | Characteristic |
|---|---|---|
| CSLZ | Usual Dose | 250 MCG/M2/DAY FOR 14 DAYS AS A 2-HOUR IV INFUSION; THE DOSE CAN BE REPEEATED AFTER 7 DAYS OFF THERAPY IF ENGRAFTMENT HAS NOT OCCURRED; IF ENGRAFTMENT STILL HAS NOT OCCURRED, A THIRD COURSE OF 500 MCG/M2/DAY FOR 14 DAYS MAY BE TRIED AFTER ANOTHER 7 DAYS OFF THERAPY |
| FEAT | Special Features | SARGRAMOSTIM 250 MCG PER VIAL; CONTAINS 250 MCG OF PRESERVATIVE-FREE LYOPHILIZED SARGRAMOSTIM; PACKAGE OF 5 VIALS; SHOULD BE REFRIGIRATED BETWEEN 2-8DEG (36-46 F); DO NOT FREEZE OR SHAKE; FOR SUBCUTANEOUS INJECTION OR IV INFUSION |
| AJCN | Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| CBBL | Features Provided | STERILE |
| CXCY | Part Name Assigned By Controlling Agency | LEUKINE (SARGRAMOSTIM) INJ, 250 MCG PER VIAL, 5'S |
| MRC | Decoded Requirement | Clear Text Reply |
| CRLK | Primary Container Content Quantity | 250.00 MICROGRAMS |
| AKJA | Active Medicament Medicinal Strength | 250.00 MICROGRAMS SARGRAMOSTIM ACTIVE INGREDIENT |
| AGXW | Physical Form | FREEZE-DRIED POWDER |
| CSGS | Administration | SUBCUTANEOUS AND INTRAVENOUS INFUSION |
| CQCT | Primary Container Type | VIAL |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote
